Mammalian oocyte therapies
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články, přehledy
PubMed
16176128
DOI
10.1089/clo.2005.7.183
Knihovny.cz E-zdroje
- MeSH
- asistovaná reprodukce * MeSH
- buněčné jádro fyziologie MeSH
- cytoplazma fyziologie transplantace MeSH
- lidé MeSH
- mitochondriální DNA genetika MeSH
- mutace MeSH
- oocyty cytologie fyziologie MeSH
- techniky jaderného přenosu * MeSH
- ženská infertilita genetika metabolismus MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Názvy látek
- mitochondriální DNA MeSH
In assisted human reproduction, the cytoplasm of oocytes recovered from follicles is often abnormal. Its lower quality, especially in older patients, may be responsible for certain chromosomal abnormalities or developmental arrest. Thus, the deficiency of some vital molecules, which are necessary for oocyte maturation, can be the cause of infertility in women. Moreover, mutated mitochondrial DNA (mtDNA) that is located in the oocyte cytoplasm might be transmitted to offspring. With the advance of new micromanipulation techniques like the oocyte nucleus replacement or cytoplasmic transfer, some of these abnormalities could be theoretically eliminated. In this review, we briefly discuss some of these approaches and their potential use in assisted human reproduction.
Citace poskytuje Crossref.org
Improving the Quality of Oocytes with the Help of Nucleolotransfer Therapy
The ups and downs of somatic cell nucleus transfer (SCNT) in humans